NIRAMAI Co-founders Geetha Manjunath (L) and Nidhi Mathur

Niramai Health Analytix, an Indian startup that has created a low-cost, non-touch, zero radiation solution to detect breast cancer, has raised an undisclosed sum in seed funding.

Bangalore-based pi Ventures led this round, with contributions from impact VC firm Ankur Capital, Axilor Ventures, 500 Startups and Flipkart Co-founder Binny Bansal.

Also Read: Indian budget hotels booking startup OYO Rooms close to raising US$250M led by SoftBank: Report

Dr. Geetha Manjunath, Co-founder and CEO of Niramai, said: “Mortality rates among breast cancer patients are very high in India. Our solution is portable, low-cost, very safe, privacy-sensitive and can detect cancer at a very early stage, making it very suitable for regular preventive health checkup as well as screening camps. This investment will help us strengthen our IP portfolio, expand operations and ensure our cancer screening tool is readily available for commercial use.”

Niramai was founded in July 2016 by Manjunath and Nidhi Mathur. Manjunath comes with 25 years of research and innovation expertise in areas such as data analytics, machine learning, cloud computing, and semantic web. Mathur is a serial intrapreneur with rich experience in business planning, strategy and product management. Both the women cofounders have previously worked with companies like Xerox Research Center and Hewlett Packard Labs.

Niramai — acronym for Non-Invasive Risk Assessment with Machine Learning — is on a mission to create a universal cancer screening method that can save lives by detecting breast cancer at an early stage. Its solution Thermalytix can remove technological, logistical and cultural barriers that hinder breast cancer screening among women today. It uses Artificial Intelligence (AI) over thermal images to address the issues of early detection of breast cancer.

The overall hardware-software solution is portable and uses Big Data analytics, AI and Machine Learning for reliable, early and accurate breast cancer screening.

Early diagnosis is critical in saving the life of a cancer patient. Niramai’s method of screening is based on principles of Thermography that can detect tumours five years before mammography or a clinical exam can detect.

The NIRAMAI team

The Niramai team

Manish Singhal, Founding Partner, pi Ventures added, “Breast Cancer is a major killer across the world. In India, one out of two women dies after getting diagnosed with breast cancer since the detection happens very late. Early detection is key to saving lives and is enabled very well with the innovative and disruptive AI based solution from Niramai.”

Also Read: If the US does not want Indian professionals it is okay, says Zoho CEO Sridhar Vembu

Ankur Capital Co-founder Dr. Ritu Verma said “Niramai’s early detection solution is low cost, zero radiation and non contact, which very effectively addresses the concerns and limitations for larger adoption of screening for women across all segments. Breast cancer rates are growing in India and having such a solution is imperative for addressing the dismal survival rates we are seeing today.”

Image Credit: Niramai

Register for your Echelon Asia Summit access pass now! Enjoy additional 10% discount on Echelon Asia Summit Startup, Investor and Corporate passes just for being our favourite e27 reader: